Hydration Pharmaceuticals Advances Toward Profitability

Hydration Pharmaceuticals Co. Ltd. (AU:HPC) has released an update.

Hydration Pharmaceuticals Co. Ltd. reports a notable 34% reduction in EBITDA losses and a 29% decrease in net cash used in operating activities, signaling strong strategic execution towards profitability. The company also saw a 52% surge in Canadian e-commerce revenue and a gross margin increase to 53%, amidst ongoing efforts to streamline costs and improve cash flow. Additionally, they are exploring strategic options, including a potential sale or asset divestiture.

For further insights into AU:HPC stock, check out TipRanks’ Stock Analysis page.